Related Experiment Video

Updated: Aug 15, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

E- and A-type cyclins as markers for cancer diagnosis and prognosis

Amber Yasmeen1, Wolfgang E Berdel, Hubert Serve

  • 1Department of Medicine, Hematology and Oncology, University of Münster, Germany.

Expert Review of Molecular Diagnostics
|September 27, 2003
PubMed

Insights

Cyclins A and E, interacting with CDK2, are crucial for cell division and cancer development. Their altered expression indicates poor prognosis and aids in cancer diagnosis and molecular diagnostics.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Cycle Regulation

Background:

  • Cyclin-dependent kinase (CDK)2 interacting cyclins are vital for DNA replication and cell proliferation.
  • Dysregulation of these cyclins, particularly E-type (E, E2) and A-type (A1, A2), is implicated in cancer pathogenesis.

Purpose of the Study:

  • To review the role of cyclins E and A as potential diagnostic and prognostic markers in human cancers.
  • To highlight the clinical significance of cyclin A2, cyclin A1, cyclin E, and cyclin E2 in various cancer types.

Main Methods:

  • Literature review of studies investigating cyclins E and A in cancer.
  • Analysis of the association between cyclin expression levels and cancer diagnosis, prognosis, and proliferation.

Main Results:

  • Cyclin A2 is a proliferation marker linked to poor prognosis in several cancers.
  • Cyclin A1 is highly expressed in acute myeloid leukemia and testicular cancer.
  • Cyclin E overexpression, including cleaved forms, is common in cancers, indicating malignancy and poor prognosis, particularly in breast and lung cancer.
  • Cyclin E2 is overexpressed in breast cancer, with its diagnostic/prognostic role under investigation.

Conclusions:

  • Cyclins A and E are significant biomarkers for cancer diagnosis and prognosis.
  • Further research into cyclin E2 may reveal its utility as a clinical marker.
  • Understanding CDK2-interacting cyclins offers insights into cancer development and therapeutic strategies.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...